(Q58113127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

title

IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

1 reference

invasive ductal carcinoma

1 reference

pancreatic ductal adenocarcinoma

inferred from title

1 reference

pancreatic ductal carcinoma

inferred from title

1 reference

Tobiloba E Oni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Benjamin Spielman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Yuan Hao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Ela Elyada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Youngkyu Park

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Jonathan Preall

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

language of work or name

English

0 references

publication date

26 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

282-301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

30 April 2020

1 reference

10 June 2022

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&rettype=xml&id=6368881

cites work

Phenotypic and functional characterization of mice that lack the type I receptor for IL-1

1 reference

12 December 2020

Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast

1 reference

12 December 2020

TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins

1 reference

12 December 2020

Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells

1 reference

12 December 2020

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

1 reference

12 December 2020

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

12 December 2020

A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells

1 reference

12 December 2020

Cancer-associated stromal fibroblasts promote pancreatic tumor progression

1 reference

12 December 2020

Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis

1 reference

12 December 2020

Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells

1 reference

12 December 2020

Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB

1 reference

12 December 2020

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

1 reference

12 December 2020

The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors

1 reference

12 December 2020

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

1 reference

12 December 2020

CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy

1 reference

12 December 2020

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

1 reference

12 December 2020

Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer

1 reference

12 December 2020

STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.

1 reference

12 December 2020

Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts

1 reference

12 December 2020

KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.

1 reference

12 December 2020

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

1 reference

12 December 2020

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

1 reference

12 December 2020

Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment

1 reference

12 December 2020

A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response

1 reference

12 December 2020

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

1 reference

12 December 2020

Bayesian approach to single-cell differential expression analysis

1 reference

12 December 2020

Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

1 reference

12 December 2020

Stromal response to Hedgehog signaling restrains pancreatic cancer progression

1 reference

12 December 2020

Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy

1 reference

12 December 2020

Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma

1 reference

12 December 2020

Organoid models of human and mouse ductal pancreatic cancer

1 reference

12 December 2020

STAT3 acts through pre-existing nucleosome-depleted regions bound by FOS during an epigenetic switch linking inflammation to cancer

1 reference

12 December 2020

Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.

1 reference

12 December 2020

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

1 reference

12 December 2020

IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation.

1 reference

12 December 2020

Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts

1 reference

12 December 2020

Cancer statistics, 2016

1 reference

12 December 2020

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression

1 reference

12 December 2020

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

1 reference

12 December 2020

Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity

1 reference

12 December 2020

Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer

1 reference

12 December 2020

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.

1 reference

12 December 2020

IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.

1 reference

12 December 2020

Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells

1 reference

12 December 2020

Tumor-stroma IL-1β-IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer

1 reference

12 December 2020

CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness

1 reference

12 December 2020

SCANPY: large-scale single-cell gene expression data analysis.

1 reference

12 December 2020

Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor.

1 reference

12 December 2020

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.

1 reference

12 December 2020

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy

1 reference

12 December 2020

Single Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression

1 reference

12 December 2020

10.1158/2159-8290.CD-18-0710

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30366930%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

PubMed publication ID

30366930

1 reference